Rong-guang Luo

P.R. China
Nanchang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Ibrutinib Inhibits Tumor Progression, Alleviates Pain, and Protects the Tibia in a Bone Metastasis Model of Lung Cancer.

Ibrutinib Inhibits Tumor Progression, Alleviates Pain, and Protects the Tibia in a Bone Metastasis Model of Lung Cancer.

Journal: Anticancer research

Published: August 31, 2025

Pharmacologic deprivation of serum inorganic phosphate ameliorates renal fibrosis via the modulation of systemic inflammation.

Pharmacologic deprivation of serum inorganic phosphate ameliorates renal fibrosis via the modulation of systemic inflammation.

Journal: European journal of pharmacology

Published: January 22, 2025

Transarterial Embolization Using an Inorganic Phosphate Binder Modulates Immunity- and Angiogenesis-Related Factors in a Rat Model of Liver Cancer.

Transarterial Embolization Using an Inorganic Phosphate Binder Modulates Immunity- and Angiogenesis-Related Factors in a Rat Model of Liver Cancer.

Journal: Journal of vascular and interventional radiology : JVIR

Published: February 29, 2024

Sevelamer reverses liver fibrosis by deactivation of hepatic stellate cells.

Sevelamer reverses liver fibrosis by deactivation of hepatic stellate cells.

Journal: Biochemical pharmacology

Published: October 28, 2023

Prediction model of no-response before the first transarterial chemoembolization for hepatocellular carcinoma: TACF score.

Prediction model of no-response before the first transarterial chemoembolization for hepatocellular carcinoma: TACF score.

Journal: Discover oncology

Published: May 10, 2023

Evaluation of the safety and efficacy of transarterial sevelamer embolization in a rabbit liver cancer model: A challenge on the size rule for vascular occlusion.

Evaluation of the safety and efficacy of transarterial sevelamer embolization in a rabbit liver cancer model: A challenge on the size rule for vascular occlusion.

Journal: Frontiers in bioengineering and biotechnology

Published: September 30, 2022

KLF14/miR-1283/TFAP2C axis inhibits HER2-positive breast cancer progression via declining tumor cell proliferation.

KLF14/miR-1283/TFAP2C axis inhibits HER2-positive breast cancer progression via declining tumor cell proliferation.

Journal: Molecular carcinogenesis

Published: June 27, 2022

Intratumoral Pi deprivation benefits chemoembolization therapy via increased accumulation of intracellular doxorubicin.

Intratumoral Pi deprivation benefits chemoembolization therapy via increased accumulation of intracellular doxorubicin.

Journal: Drug delivery

Published: May 31, 2022

Sevelamer arsenite nanoparticle as a Pi-responsive drug carrier and embolic agent for chemoembolization.

Sevelamer arsenite nanoparticle as a Pi-responsive drug carrier and embolic agent for chemoembolization.

Journal: Drug delivery

Published: May 09, 2022

Pi-inducedin-situaggregation of sevelamer nanoparticles for vascular embolization.

Pi-inducedin-situaggregation of sevelamer nanoparticles for vascular embolization.

Journal: Nanotechnology

Published: December 24, 2021

Circular RNA circ-ERBB2 promotes HER2-positive breast cancer progression and metastasis via sponging miR-136-5p and miR-198.

Circular RNA circ-ERBB2 promotes HER2-positive breast cancer progression and metastasis via sponging miR-136-5p and miR-198.

Journal: Journal of translational medicine

Published: August 08, 2021

Nanosized drug-eluting bead for transcatheter arterial chemoembolization (ND-TACE).

Nanosized drug-eluting bead for transcatheter arterial chemoembolization (ND-TACE).

Journal: Journal of materials chemistry. B

Published: August 29, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026